Merck & Co., Inc. (LON:0QAH)
London · Delayed Price · Currency is GBP · Price in USD 104.83
-0.45 (-0.43%)
At close: Nov 28, 2025
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of 196.56 billion as of November 28, 2025. Its market cap has increased by 0.48% in one year.
Market Cap
196.56B
Enterprise Value
214.10B
Revenue
47.79B
Ranking
n/a
PE Ratio
13.88
Stock Price
104.83
Market Cap Chart
Since January 2, 1968, Merck & Co.'s market cap has increased from 3.01B to 196.56B, an increase of 6,439.41%. That is a compound annual growth rate of 7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 196.56B | -2.21% |
| Dec 31, 2024 | 201.01B | -7.32% |
| Dec 29, 2023 | 216.89B | -7.10% |
| Dec 30, 2022 | 233.47B | 63.30% |
| Dec 31, 2021 | 142.97B | -5.68% |
| Dec 31, 2020 | 151.58B | -13.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.39B |
| GSK plc | 72.88B |
| Haleon | 33.03B |
| Smith & Nephew | 10.71B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 3.45B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.64B |